Medical Care
Recombinant DNA Technology - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Sep 18, 24
- ID: 550901
- Pages: 130
- Figures: 210
- Views: 1
The global market for Recombinant DNA Technology was estimated to be worth US$ 3023.5 million in 2023 and is forecast to a readjusted size of US$ 5388.6 million by 2030 with a CAGR of 8.6% during the forecast period 2024-2030
North American market for Recombinant DNA Technology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Recombinant DNA Technology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Recombinant DNA Technology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Recombinant DNA Technology include Monsanto Company, Roche, Biogen, Amgen, Novartis, Eli Lilly and Company, GenScript, Pfizer Inc. and Novo Nordisk, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Recombinant DNA Technology, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Recombinant DNA Technology by region & country, by Type, and by Application.
The Recombinant DNA Technology market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant DNA Technology.
Market Segmentation
By Company
Monsanto Company
Roche
Biogen
Amgen
Novartis
Eli Lilly and Company
GenScript
Pfizer Inc.
Novo Nordisk
Sanofi
Merck KGaA
Profacgen
Biocon
GlaxoSmithKline
Cibus
Horizon Discovery Group
New England Biolabs
Segment by Type:
Therapeutic Agent
Vaccine
Biotech Crops
Specialty Chemicals
Segment by Application
Biotechnology and Pharmaceutical Companies
Academic & Government Research Institutes
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Recombinant DNA Technology manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Recombinant DNA Technology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Recombinant DNA Technology in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
North American market for Recombinant DNA Technology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Recombinant DNA Technology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Recombinant DNA Technology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Recombinant DNA Technology include Monsanto Company, Roche, Biogen, Amgen, Novartis, Eli Lilly and Company, GenScript, Pfizer Inc. and Novo Nordisk, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Recombinant DNA Technology, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Recombinant DNA Technology by region & country, by Type, and by Application.
The Recombinant DNA Technology market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant DNA Technology.
Market Segmentation
By Company
Monsanto Company
Roche
Biogen
Amgen
Novartis
Eli Lilly and Company
GenScript
Pfizer Inc.
Novo Nordisk
Sanofi
Merck KGaA
Profacgen
Biocon
GlaxoSmithKline
Cibus
Horizon Discovery Group
New England Biolabs
Segment by Type:
Therapeutic Agent
Vaccine
Biotech Crops
Specialty Chemicals
Segment by Application
Biotechnology and Pharmaceutical Companies
Academic & Government Research Institutes
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Recombinant DNA Technology manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Recombinant DNA Technology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Recombinant DNA Technology in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Recombinant DNA Technology Product Introduction
1.2 Global Recombinant DNA Technology Market Size Forecast
1.3 Recombinant DNA Technology Market Trends & Drivers
1.3.1 Recombinant DNA Technology Industry Trends
1.3.2 Recombinant DNA Technology Market Drivers & Opportunity
1.3.3 Recombinant DNA Technology Market Challenges
1.3.4 Recombinant DNA Technology Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Recombinant DNA Technology Players Revenue Ranking (2023)
2.2 Global Recombinant DNA Technology Revenue by Company (2019-2024)
2.3 Key Companies Recombinant DNA Technology Manufacturing Base Distribution and Headquarters
2.4 Key Companies Recombinant DNA Technology Product Offered
2.5 Key Companies Time to Begin Mass Production of Recombinant DNA Technology
2.6 Recombinant DNA Technology Market Competitive Analysis
2.6.1 Recombinant DNA Technology Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Recombinant DNA Technology Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant DNA Technology as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Therapeutic Agent
3.1.2 Vaccine
3.1.3 Biotech Crops
3.1.4 Specialty Chemicals
3.2 Global Recombinant DNA Technology Sales Value by Type
3.2.1 Global Recombinant DNA Technology Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Recombinant DNA Technology Sales Value, by Type (2019-2030)
3.2.3 Global Recombinant DNA Technology Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Biotechnology and Pharmaceutical Companies
4.1.2 Academic & Government Research Institutes
4.1.3 Others
4.2 Global Recombinant DNA Technology Sales Value by Application
4.2.1 Global Recombinant DNA Technology Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Recombinant DNA Technology Sales Value, by Application (2019-2030)
4.2.3 Global Recombinant DNA Technology Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Recombinant DNA Technology Sales Value by Region
5.1.1 Global Recombinant DNA Technology Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Recombinant DNA Technology Sales Value by Region (2019-2024)
5.1.3 Global Recombinant DNA Technology Sales Value by Region (2025-2030)
5.1.4 Global Recombinant DNA Technology Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Recombinant DNA Technology Sales Value, 2019-2030
5.2.2 North America Recombinant DNA Technology Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Recombinant DNA Technology Sales Value, 2019-2030
5.3.2 Europe Recombinant DNA Technology Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Recombinant DNA Technology Sales Value, 2019-2030
5.4.2 Asia Pacific Recombinant DNA Technology Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Recombinant DNA Technology Sales Value, 2019-2030
5.5.2 South America Recombinant DNA Technology Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Recombinant DNA Technology Sales Value, 2019-2030
5.6.2 Middle East & Africa Recombinant DNA Technology Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Recombinant DNA Technology Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Recombinant DNA Technology Sales Value
6.3 United States
6.3.1 United States Recombinant DNA Technology Sales Value, 2019-2030
6.3.2 United States Recombinant DNA Technology Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Recombinant DNA Technology Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Recombinant DNA Technology Sales Value, 2019-2030
6.4.2 Europe Recombinant DNA Technology Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Recombinant DNA Technology Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Recombinant DNA Technology Sales Value, 2019-2030
6.5.2 China Recombinant DNA Technology Sales Value by Type (%), 2023 VS 2030
6.5.3 China Recombinant DNA Technology Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Recombinant DNA Technology Sales Value, 2019-2030
6.6.2 Japan Recombinant DNA Technology Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Recombinant DNA Technology Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Recombinant DNA Technology Sales Value, 2019-2030
6.7.2 South Korea Recombinant DNA Technology Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Recombinant DNA Technology Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Recombinant DNA Technology Sales Value, 2019-2030
6.8.2 Southeast Asia Recombinant DNA Technology Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Recombinant DNA Technology Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Recombinant DNA Technology Sales Value, 2019-2030
6.9.2 India Recombinant DNA Technology Sales Value by Type (%), 2023 VS 2030
6.9.3 India Recombinant DNA Technology Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Monsanto Company
7.1.1 Monsanto Company Profile
7.1.2 Monsanto Company Main Business
7.1.3 Monsanto Company Recombinant DNA Technology Products, Services and Solutions
7.1.4 Monsanto Company Recombinant DNA Technology Revenue (US$ Million) & (2019-2024)
7.1.5 Monsanto Company Recent Developments
7.2 Roche
7.2.1 Roche Profile
7.2.2 Roche Main Business
7.2.3 Roche Recombinant DNA Technology Products, Services and Solutions
7.2.4 Roche Recombinant DNA Technology Revenue (US$ Million) & (2019-2024)
7.2.5 Roche Recent Developments
7.3 Biogen
7.3.1 Biogen Profile
7.3.2 Biogen Main Business
7.3.3 Biogen Recombinant DNA Technology Products, Services and Solutions
7.3.4 Biogen Recombinant DNA Technology Revenue (US$ Million) & (2019-2024)
7.3.5 Amgen Recent Developments
7.4 Amgen
7.4.1 Amgen Profile
7.4.2 Amgen Main Business
7.4.3 Amgen Recombinant DNA Technology Products, Services and Solutions
7.4.4 Amgen Recombinant DNA Technology Revenue (US$ Million) & (2019-2024)
7.4.5 Amgen Recent Developments
7.5 Novartis
7.5.1 Novartis Profile
7.5.2 Novartis Main Business
7.5.3 Novartis Recombinant DNA Technology Products, Services and Solutions
7.5.4 Novartis Recombinant DNA Technology Revenue (US$ Million) & (2019-2024)
7.5.5 Novartis Recent Developments
7.6 Eli Lilly and Company
7.6.1 Eli Lilly and Company Profile
7.6.2 Eli Lilly and Company Main Business
7.6.3 Eli Lilly and Company Recombinant DNA Technology Products, Services and Solutions
7.6.4 Eli Lilly and Company Recombinant DNA Technology Revenue (US$ Million) & (2019-2024)
7.6.5 Eli Lilly and Company Recent Developments
7.7 GenScript
7.7.1 GenScript Profile
7.7.2 GenScript Main Business
7.7.3 GenScript Recombinant DNA Technology Products, Services and Solutions
7.7.4 GenScript Recombinant DNA Technology Revenue (US$ Million) & (2019-2024)
7.7.5 GenScript Recent Developments
7.8 Pfizer Inc.
7.8.1 Pfizer Inc. Profile
7.8.2 Pfizer Inc. Main Business
7.8.3 Pfizer Inc. Recombinant DNA Technology Products, Services and Solutions
7.8.4 Pfizer Inc. Recombinant DNA Technology Revenue (US$ Million) & (2019-2024)
7.8.5 Pfizer Inc. Recent Developments
7.9 Novo Nordisk
7.9.1 Novo Nordisk Profile
7.9.2 Novo Nordisk Main Business
7.9.3 Novo Nordisk Recombinant DNA Technology Products, Services and Solutions
7.9.4 Novo Nordisk Recombinant DNA Technology Revenue (US$ Million) & (2019-2024)
7.9.5 Novo Nordisk Recent Developments
7.10 Sanofi
7.10.1 Sanofi Profile
7.10.2 Sanofi Main Business
7.10.3 Sanofi Recombinant DNA Technology Products, Services and Solutions
7.10.4 Sanofi Recombinant DNA Technology Revenue (US$ Million) & (2019-2024)
7.10.5 Sanofi Recent Developments
7.11 Merck KGaA
7.11.1 Merck KGaA Profile
7.11.2 Merck KGaA Main Business
7.11.3 Merck KGaA Recombinant DNA Technology Products, Services and Solutions
7.11.4 Merck KGaA Recombinant DNA Technology Revenue (US$ Million) & (2019-2024)
7.11.5 Merck KGaA Recent Developments
7.12 Profacgen
7.12.1 Profacgen Profile
7.12.2 Profacgen Main Business
7.12.3 Profacgen Recombinant DNA Technology Products, Services and Solutions
7.12.4 Profacgen Recombinant DNA Technology Revenue (US$ Million) & (2019-2024)
7.12.5 Profacgen Recent Developments
7.13 Biocon
7.13.1 Biocon Profile
7.13.2 Biocon Main Business
7.13.3 Biocon Recombinant DNA Technology Products, Services and Solutions
7.13.4 Biocon Recombinant DNA Technology Revenue (US$ Million) & (2019-2024)
7.13.5 Biocon Recent Developments
7.14 GlaxoSmithKline
7.14.1 GlaxoSmithKline Profile
7.14.2 GlaxoSmithKline Main Business
7.14.3 GlaxoSmithKline Recombinant DNA Technology Products, Services and Solutions
7.14.4 GlaxoSmithKline Recombinant DNA Technology Revenue (US$ Million) & (2019-2024)
7.14.5 GlaxoSmithKline Recent Developments
7.15 Cibus
7.15.1 Cibus Profile
7.15.2 Cibus Main Business
7.15.3 Cibus Recombinant DNA Technology Products, Services and Solutions
7.15.4 Cibus Recombinant DNA Technology Revenue (US$ Million) & (2019-2024)
7.15.5 Cibus Recent Developments
7.16 Horizon Discovery Group
7.16.1 Horizon Discovery Group Profile
7.16.2 Horizon Discovery Group Main Business
7.16.3 Horizon Discovery Group Recombinant DNA Technology Products, Services and Solutions
7.16.4 Horizon Discovery Group Recombinant DNA Technology Revenue (US$ Million) & (2019-2024)
7.16.5 Horizon Discovery Group Recent Developments
7.17 New England Biolabs
7.17.1 New England Biolabs Profile
7.17.2 New England Biolabs Main Business
7.17.3 New England Biolabs Recombinant DNA Technology Products, Services and Solutions
7.17.4 New England Biolabs Recombinant DNA Technology Revenue (US$ Million) & (2019-2024)
7.17.5 New England Biolabs Recent Developments
8 Industry Chain Analysis
8.1 Recombinant DNA Technology Industrial Chain
8.2 Recombinant DNA Technology Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Recombinant DNA Technology Sales Model
8.5.2 Sales Channel
8.5.3 Recombinant DNA Technology Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Recombinant DNA Technology Product Introduction
1.2 Global Recombinant DNA Technology Market Size Forecast
1.3 Recombinant DNA Technology Market Trends & Drivers
1.3.1 Recombinant DNA Technology Industry Trends
1.3.2 Recombinant DNA Technology Market Drivers & Opportunity
1.3.3 Recombinant DNA Technology Market Challenges
1.3.4 Recombinant DNA Technology Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Recombinant DNA Technology Players Revenue Ranking (2023)
2.2 Global Recombinant DNA Technology Revenue by Company (2019-2024)
2.3 Key Companies Recombinant DNA Technology Manufacturing Base Distribution and Headquarters
2.4 Key Companies Recombinant DNA Technology Product Offered
2.5 Key Companies Time to Begin Mass Production of Recombinant DNA Technology
2.6 Recombinant DNA Technology Market Competitive Analysis
2.6.1 Recombinant DNA Technology Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Recombinant DNA Technology Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant DNA Technology as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Therapeutic Agent
3.1.2 Vaccine
3.1.3 Biotech Crops
3.1.4 Specialty Chemicals
3.2 Global Recombinant DNA Technology Sales Value by Type
3.2.1 Global Recombinant DNA Technology Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Recombinant DNA Technology Sales Value, by Type (2019-2030)
3.2.3 Global Recombinant DNA Technology Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Biotechnology and Pharmaceutical Companies
4.1.2 Academic & Government Research Institutes
4.1.3 Others
4.2 Global Recombinant DNA Technology Sales Value by Application
4.2.1 Global Recombinant DNA Technology Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Recombinant DNA Technology Sales Value, by Application (2019-2030)
4.2.3 Global Recombinant DNA Technology Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Recombinant DNA Technology Sales Value by Region
5.1.1 Global Recombinant DNA Technology Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Recombinant DNA Technology Sales Value by Region (2019-2024)
5.1.3 Global Recombinant DNA Technology Sales Value by Region (2025-2030)
5.1.4 Global Recombinant DNA Technology Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Recombinant DNA Technology Sales Value, 2019-2030
5.2.2 North America Recombinant DNA Technology Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Recombinant DNA Technology Sales Value, 2019-2030
5.3.2 Europe Recombinant DNA Technology Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Recombinant DNA Technology Sales Value, 2019-2030
5.4.2 Asia Pacific Recombinant DNA Technology Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Recombinant DNA Technology Sales Value, 2019-2030
5.5.2 South America Recombinant DNA Technology Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Recombinant DNA Technology Sales Value, 2019-2030
5.6.2 Middle East & Africa Recombinant DNA Technology Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Recombinant DNA Technology Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Recombinant DNA Technology Sales Value
6.3 United States
6.3.1 United States Recombinant DNA Technology Sales Value, 2019-2030
6.3.2 United States Recombinant DNA Technology Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Recombinant DNA Technology Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Recombinant DNA Technology Sales Value, 2019-2030
6.4.2 Europe Recombinant DNA Technology Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Recombinant DNA Technology Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Recombinant DNA Technology Sales Value, 2019-2030
6.5.2 China Recombinant DNA Technology Sales Value by Type (%), 2023 VS 2030
6.5.3 China Recombinant DNA Technology Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Recombinant DNA Technology Sales Value, 2019-2030
6.6.2 Japan Recombinant DNA Technology Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Recombinant DNA Technology Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Recombinant DNA Technology Sales Value, 2019-2030
6.7.2 South Korea Recombinant DNA Technology Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Recombinant DNA Technology Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Recombinant DNA Technology Sales Value, 2019-2030
6.8.2 Southeast Asia Recombinant DNA Technology Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Recombinant DNA Technology Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Recombinant DNA Technology Sales Value, 2019-2030
6.9.2 India Recombinant DNA Technology Sales Value by Type (%), 2023 VS 2030
6.9.3 India Recombinant DNA Technology Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Monsanto Company
7.1.1 Monsanto Company Profile
7.1.2 Monsanto Company Main Business
7.1.3 Monsanto Company Recombinant DNA Technology Products, Services and Solutions
7.1.4 Monsanto Company Recombinant DNA Technology Revenue (US$ Million) & (2019-2024)
7.1.5 Monsanto Company Recent Developments
7.2 Roche
7.2.1 Roche Profile
7.2.2 Roche Main Business
7.2.3 Roche Recombinant DNA Technology Products, Services and Solutions
7.2.4 Roche Recombinant DNA Technology Revenue (US$ Million) & (2019-2024)
7.2.5 Roche Recent Developments
7.3 Biogen
7.3.1 Biogen Profile
7.3.2 Biogen Main Business
7.3.3 Biogen Recombinant DNA Technology Products, Services and Solutions
7.3.4 Biogen Recombinant DNA Technology Revenue (US$ Million) & (2019-2024)
7.3.5 Amgen Recent Developments
7.4 Amgen
7.4.1 Amgen Profile
7.4.2 Amgen Main Business
7.4.3 Amgen Recombinant DNA Technology Products, Services and Solutions
7.4.4 Amgen Recombinant DNA Technology Revenue (US$ Million) & (2019-2024)
7.4.5 Amgen Recent Developments
7.5 Novartis
7.5.1 Novartis Profile
7.5.2 Novartis Main Business
7.5.3 Novartis Recombinant DNA Technology Products, Services and Solutions
7.5.4 Novartis Recombinant DNA Technology Revenue (US$ Million) & (2019-2024)
7.5.5 Novartis Recent Developments
7.6 Eli Lilly and Company
7.6.1 Eli Lilly and Company Profile
7.6.2 Eli Lilly and Company Main Business
7.6.3 Eli Lilly and Company Recombinant DNA Technology Products, Services and Solutions
7.6.4 Eli Lilly and Company Recombinant DNA Technology Revenue (US$ Million) & (2019-2024)
7.6.5 Eli Lilly and Company Recent Developments
7.7 GenScript
7.7.1 GenScript Profile
7.7.2 GenScript Main Business
7.7.3 GenScript Recombinant DNA Technology Products, Services and Solutions
7.7.4 GenScript Recombinant DNA Technology Revenue (US$ Million) & (2019-2024)
7.7.5 GenScript Recent Developments
7.8 Pfizer Inc.
7.8.1 Pfizer Inc. Profile
7.8.2 Pfizer Inc. Main Business
7.8.3 Pfizer Inc. Recombinant DNA Technology Products, Services and Solutions
7.8.4 Pfizer Inc. Recombinant DNA Technology Revenue (US$ Million) & (2019-2024)
7.8.5 Pfizer Inc. Recent Developments
7.9 Novo Nordisk
7.9.1 Novo Nordisk Profile
7.9.2 Novo Nordisk Main Business
7.9.3 Novo Nordisk Recombinant DNA Technology Products, Services and Solutions
7.9.4 Novo Nordisk Recombinant DNA Technology Revenue (US$ Million) & (2019-2024)
7.9.5 Novo Nordisk Recent Developments
7.10 Sanofi
7.10.1 Sanofi Profile
7.10.2 Sanofi Main Business
7.10.3 Sanofi Recombinant DNA Technology Products, Services and Solutions
7.10.4 Sanofi Recombinant DNA Technology Revenue (US$ Million) & (2019-2024)
7.10.5 Sanofi Recent Developments
7.11 Merck KGaA
7.11.1 Merck KGaA Profile
7.11.2 Merck KGaA Main Business
7.11.3 Merck KGaA Recombinant DNA Technology Products, Services and Solutions
7.11.4 Merck KGaA Recombinant DNA Technology Revenue (US$ Million) & (2019-2024)
7.11.5 Merck KGaA Recent Developments
7.12 Profacgen
7.12.1 Profacgen Profile
7.12.2 Profacgen Main Business
7.12.3 Profacgen Recombinant DNA Technology Products, Services and Solutions
7.12.4 Profacgen Recombinant DNA Technology Revenue (US$ Million) & (2019-2024)
7.12.5 Profacgen Recent Developments
7.13 Biocon
7.13.1 Biocon Profile
7.13.2 Biocon Main Business
7.13.3 Biocon Recombinant DNA Technology Products, Services and Solutions
7.13.4 Biocon Recombinant DNA Technology Revenue (US$ Million) & (2019-2024)
7.13.5 Biocon Recent Developments
7.14 GlaxoSmithKline
7.14.1 GlaxoSmithKline Profile
7.14.2 GlaxoSmithKline Main Business
7.14.3 GlaxoSmithKline Recombinant DNA Technology Products, Services and Solutions
7.14.4 GlaxoSmithKline Recombinant DNA Technology Revenue (US$ Million) & (2019-2024)
7.14.5 GlaxoSmithKline Recent Developments
7.15 Cibus
7.15.1 Cibus Profile
7.15.2 Cibus Main Business
7.15.3 Cibus Recombinant DNA Technology Products, Services and Solutions
7.15.4 Cibus Recombinant DNA Technology Revenue (US$ Million) & (2019-2024)
7.15.5 Cibus Recent Developments
7.16 Horizon Discovery Group
7.16.1 Horizon Discovery Group Profile
7.16.2 Horizon Discovery Group Main Business
7.16.3 Horizon Discovery Group Recombinant DNA Technology Products, Services and Solutions
7.16.4 Horizon Discovery Group Recombinant DNA Technology Revenue (US$ Million) & (2019-2024)
7.16.5 Horizon Discovery Group Recent Developments
7.17 New England Biolabs
7.17.1 New England Biolabs Profile
7.17.2 New England Biolabs Main Business
7.17.3 New England Biolabs Recombinant DNA Technology Products, Services and Solutions
7.17.4 New England Biolabs Recombinant DNA Technology Revenue (US$ Million) & (2019-2024)
7.17.5 New England Biolabs Recent Developments
8 Industry Chain Analysis
8.1 Recombinant DNA Technology Industrial Chain
8.2 Recombinant DNA Technology Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Recombinant DNA Technology Sales Model
8.5.2 Sales Channel
8.5.3 Recombinant DNA Technology Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Recombinant DNA Technology Market Trends
Table 2. Recombinant DNA Technology Market Drivers & Opportunity
Table 3. Recombinant DNA Technology Market Challenges
Table 4. Recombinant DNA Technology Market Restraints
Table 5. Global Recombinant DNA Technology Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Recombinant DNA Technology Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Recombinant DNA Technology Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Recombinant DNA Technology Product Type
Table 9. Key Companies Time to Begin Mass Production of Recombinant DNA Technology
Table 10. Global Recombinant DNA Technology Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant DNA Technology as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Recombinant DNA Technology Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Recombinant DNA Technology Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Recombinant DNA Technology Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Recombinant DNA Technology Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Recombinant DNA Technology Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Recombinant DNA Technology Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Recombinant DNA Technology Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Recombinant DNA Technology Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Recombinant DNA Technology Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Recombinant DNA Technology Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Recombinant DNA Technology Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Recombinant DNA Technology Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Recombinant DNA Technology Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Recombinant DNA Technology Sales Value by Region (2019-2024) & (%)
Table 27. Global Recombinant DNA Technology Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Recombinant DNA Technology Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Recombinant DNA Technology Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Recombinant DNA Technology Sales Value, (2025-2030) & (US$ Million)
Table 31. Monsanto Company Basic Information List
Table 32. Monsanto Company Description and Business Overview
Table 33. Monsanto Company Recombinant DNA Technology Products, Services and Solutions
Table 34. Revenue (US$ Million) in Recombinant DNA Technology Business of Monsanto Company (2019-2024)
Table 35. Monsanto Company Recent Developments
Table 36. Roche Basic Information List
Table 37. Roche Description and Business Overview
Table 38. Roche Recombinant DNA Technology Products, Services and Solutions
Table 39. Revenue (US$ Million) in Recombinant DNA Technology Business of Roche (2019-2024)
Table 40. Roche Recent Developments
Table 41. Biogen Basic Information List
Table 42. Biogen Description and Business Overview
Table 43. Biogen Recombinant DNA Technology Products, Services and Solutions
Table 44. Revenue (US$ Million) in Recombinant DNA Technology Business of Biogen (2019-2024)
Table 45. Biogen Recent Developments
Table 46. Amgen Basic Information List
Table 47. Amgen Description and Business Overview
Table 48. Amgen Recombinant DNA Technology Products, Services and Solutions
Table 49. Revenue (US$ Million) in Recombinant DNA Technology Business of Amgen (2019-2024)
Table 50. Amgen Recent Developments
Table 51. Novartis Basic Information List
Table 52. Novartis Description and Business Overview
Table 53. Novartis Recombinant DNA Technology Products, Services and Solutions
Table 54. Revenue (US$ Million) in Recombinant DNA Technology Business of Novartis (2019-2024)
Table 55. Novartis Recent Developments
Table 56. Eli Lilly and Company Basic Information List
Table 57. Eli Lilly and Company Description and Business Overview
Table 58. Eli Lilly and Company Recombinant DNA Technology Products, Services and Solutions
Table 59. Revenue (US$ Million) in Recombinant DNA Technology Business of Eli Lilly and Company (2019-2024)
Table 60. Eli Lilly and Company Recent Developments
Table 61. GenScript Basic Information List
Table 62. GenScript Description and Business Overview
Table 63. GenScript Recombinant DNA Technology Products, Services and Solutions
Table 64. Revenue (US$ Million) in Recombinant DNA Technology Business of GenScript (2019-2024)
Table 65. GenScript Recent Developments
Table 66. Pfizer Inc. Basic Information List
Table 67. Pfizer Inc. Description and Business Overview
Table 68. Pfizer Inc. Recombinant DNA Technology Products, Services and Solutions
Table 69. Revenue (US$ Million) in Recombinant DNA Technology Business of Pfizer Inc. (2019-2024)
Table 70. Pfizer Inc. Recent Developments
Table 71. Novo Nordisk Basic Information List
Table 72. Novo Nordisk Description and Business Overview
Table 73. Novo Nordisk Recombinant DNA Technology Products, Services and Solutions
Table 74. Revenue (US$ Million) in Recombinant DNA Technology Business of Novo Nordisk (2019-2024)
Table 75. Novo Nordisk Recent Developments
Table 76. Sanofi Basic Information List
Table 77. Sanofi Description and Business Overview
Table 78. Sanofi Recombinant DNA Technology Products, Services and Solutions
Table 79. Revenue (US$ Million) in Recombinant DNA Technology Business of Sanofi (2019-2024)
Table 80. Sanofi Recent Developments
Table 81. Merck KGaA Basic Information List
Table 82. Merck KGaA Description and Business Overview
Table 83. Merck KGaA Recombinant DNA Technology Products, Services and Solutions
Table 84. Revenue (US$ Million) in Recombinant DNA Technology Business of Merck KGaA (2019-2024)
Table 85. Merck KGaA Recent Developments
Table 86. Profacgen Basic Information List
Table 87. Profacgen Description and Business Overview
Table 88. Profacgen Recombinant DNA Technology Products, Services and Solutions
Table 89. Revenue (US$ Million) in Recombinant DNA Technology Business of Profacgen (2019-2024)
Table 90. Profacgen Recent Developments
Table 91. Biocon Basic Information List
Table 92. Biocon Description and Business Overview
Table 93. Biocon Recombinant DNA Technology Products, Services and Solutions
Table 94. Revenue (US$ Million) in Recombinant DNA Technology Business of Biocon (2019-2024)
Table 95. Biocon Recent Developments
Table 96. GlaxoSmithKline Basic Information List
Table 97. GlaxoSmithKline Description and Business Overview
Table 98. GlaxoSmithKline Recombinant DNA Technology Products, Services and Solutions
Table 99. Revenue (US$ Million) in Recombinant DNA Technology Business of GlaxoSmithKline (2019-2024)
Table 100. GlaxoSmithKline Recent Developments
Table 101. Cibus Basic Information List
Table 102. Cibus Description and Business Overview
Table 103. Cibus Recombinant DNA Technology Products, Services and Solutions
Table 104. Revenue (US$ Million) in Recombinant DNA Technology Business of Cibus (2019-2024)
Table 105. Cibus Recent Developments
Table 106. Horizon Discovery Group Basic Information List
Table 107. Horizon Discovery Group Description and Business Overview
Table 108. Horizon Discovery Group Recombinant DNA Technology Products, Services and Solutions
Table 109. Revenue (US$ Million) in Recombinant DNA Technology Business of Horizon Discovery Group (2019-2024)
Table 110. Horizon Discovery Group Recent Developments
Table 111. New England Biolabs Basic Information List
Table 112. New England Biolabs Description and Business Overview
Table 113. New England Biolabs Recombinant DNA Technology Products, Services and Solutions
Table 114. Revenue (US$ Million) in Recombinant DNA Technology Business of New England Biolabs (2019-2024)
Table 115. New England Biolabs Recent Developments
Table 116. Key Raw Materials Lists
Table 117. Raw Materials Key Suppliers Lists
Table 118. Recombinant DNA Technology Downstream Customers
Table 119. Recombinant DNA Technology Distributors List
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
Table 123. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Recombinant DNA Technology Product Picture
Figure 2. Global Recombinant DNA Technology Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Recombinant DNA Technology Sales Value (2019-2030) & (US$ Million)
Figure 4. Recombinant DNA Technology Report Years Considered
Figure 5. Global Recombinant DNA Technology Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Recombinant DNA Technology Revenue in 2023
Figure 7. Recombinant DNA Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Therapeutic Agent Picture
Figure 9. Vaccine Picture
Figure 10. Biotech Crops Picture
Figure 11. Specialty Chemicals Picture
Figure 12. Global Recombinant DNA Technology Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Recombinant DNA Technology Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Biotechnology and Pharmaceutical Companies
Figure 15. Product Picture of Academic & Government Research Institutes
Figure 16. Product Picture of Others
Figure 17. Global Recombinant DNA Technology Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Recombinant DNA Technology Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Recombinant DNA Technology Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Recombinant DNA Technology Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Recombinant DNA Technology Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Recombinant DNA Technology Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Recombinant DNA Technology Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Recombinant DNA Technology Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Recombinant DNA Technology Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Recombinant DNA Technology Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Recombinant DNA Technology Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Recombinant DNA Technology Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Recombinant DNA Technology Sales Value (%), (2019-2030)
Figure 30. United States Recombinant DNA Technology Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Recombinant DNA Technology Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Recombinant DNA Technology Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Recombinant DNA Technology Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Recombinant DNA Technology Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Recombinant DNA Technology Sales Value by Application (%), 2023 VS 2030
Figure 36. China Recombinant DNA Technology Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Recombinant DNA Technology Sales Value by Type (%), 2023 VS 2030
Figure 38. China Recombinant DNA Technology Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Recombinant DNA Technology Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Recombinant DNA Technology Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Recombinant DNA Technology Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Recombinant DNA Technology Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Recombinant DNA Technology Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Recombinant DNA Technology Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Recombinant DNA Technology Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Recombinant DNA Technology Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Recombinant DNA Technology Sales Value by Application (%), 2023 VS 2030
Figure 48. India Recombinant DNA Technology Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Recombinant DNA Technology Sales Value by Type (%), 2023 VS 2030
Figure 50. India Recombinant DNA Technology Sales Value by Application (%), 2023 VS 2030
Figure 51. Recombinant DNA Technology Industrial Chain
Figure 52. Recombinant DNA Technology Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Table 1. Recombinant DNA Technology Market Trends
Table 2. Recombinant DNA Technology Market Drivers & Opportunity
Table 3. Recombinant DNA Technology Market Challenges
Table 4. Recombinant DNA Technology Market Restraints
Table 5. Global Recombinant DNA Technology Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Recombinant DNA Technology Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Recombinant DNA Technology Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Recombinant DNA Technology Product Type
Table 9. Key Companies Time to Begin Mass Production of Recombinant DNA Technology
Table 10. Global Recombinant DNA Technology Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant DNA Technology as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Recombinant DNA Technology Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Recombinant DNA Technology Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Recombinant DNA Technology Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Recombinant DNA Technology Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Recombinant DNA Technology Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Recombinant DNA Technology Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Recombinant DNA Technology Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Recombinant DNA Technology Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Recombinant DNA Technology Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Recombinant DNA Technology Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Recombinant DNA Technology Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Recombinant DNA Technology Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Recombinant DNA Technology Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Recombinant DNA Technology Sales Value by Region (2019-2024) & (%)
Table 27. Global Recombinant DNA Technology Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Recombinant DNA Technology Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Recombinant DNA Technology Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Recombinant DNA Technology Sales Value, (2025-2030) & (US$ Million)
Table 31. Monsanto Company Basic Information List
Table 32. Monsanto Company Description and Business Overview
Table 33. Monsanto Company Recombinant DNA Technology Products, Services and Solutions
Table 34. Revenue (US$ Million) in Recombinant DNA Technology Business of Monsanto Company (2019-2024)
Table 35. Monsanto Company Recent Developments
Table 36. Roche Basic Information List
Table 37. Roche Description and Business Overview
Table 38. Roche Recombinant DNA Technology Products, Services and Solutions
Table 39. Revenue (US$ Million) in Recombinant DNA Technology Business of Roche (2019-2024)
Table 40. Roche Recent Developments
Table 41. Biogen Basic Information List
Table 42. Biogen Description and Business Overview
Table 43. Biogen Recombinant DNA Technology Products, Services and Solutions
Table 44. Revenue (US$ Million) in Recombinant DNA Technology Business of Biogen (2019-2024)
Table 45. Biogen Recent Developments
Table 46. Amgen Basic Information List
Table 47. Amgen Description and Business Overview
Table 48. Amgen Recombinant DNA Technology Products, Services and Solutions
Table 49. Revenue (US$ Million) in Recombinant DNA Technology Business of Amgen (2019-2024)
Table 50. Amgen Recent Developments
Table 51. Novartis Basic Information List
Table 52. Novartis Description and Business Overview
Table 53. Novartis Recombinant DNA Technology Products, Services and Solutions
Table 54. Revenue (US$ Million) in Recombinant DNA Technology Business of Novartis (2019-2024)
Table 55. Novartis Recent Developments
Table 56. Eli Lilly and Company Basic Information List
Table 57. Eli Lilly and Company Description and Business Overview
Table 58. Eli Lilly and Company Recombinant DNA Technology Products, Services and Solutions
Table 59. Revenue (US$ Million) in Recombinant DNA Technology Business of Eli Lilly and Company (2019-2024)
Table 60. Eli Lilly and Company Recent Developments
Table 61. GenScript Basic Information List
Table 62. GenScript Description and Business Overview
Table 63. GenScript Recombinant DNA Technology Products, Services and Solutions
Table 64. Revenue (US$ Million) in Recombinant DNA Technology Business of GenScript (2019-2024)
Table 65. GenScript Recent Developments
Table 66. Pfizer Inc. Basic Information List
Table 67. Pfizer Inc. Description and Business Overview
Table 68. Pfizer Inc. Recombinant DNA Technology Products, Services and Solutions
Table 69. Revenue (US$ Million) in Recombinant DNA Technology Business of Pfizer Inc. (2019-2024)
Table 70. Pfizer Inc. Recent Developments
Table 71. Novo Nordisk Basic Information List
Table 72. Novo Nordisk Description and Business Overview
Table 73. Novo Nordisk Recombinant DNA Technology Products, Services and Solutions
Table 74. Revenue (US$ Million) in Recombinant DNA Technology Business of Novo Nordisk (2019-2024)
Table 75. Novo Nordisk Recent Developments
Table 76. Sanofi Basic Information List
Table 77. Sanofi Description and Business Overview
Table 78. Sanofi Recombinant DNA Technology Products, Services and Solutions
Table 79. Revenue (US$ Million) in Recombinant DNA Technology Business of Sanofi (2019-2024)
Table 80. Sanofi Recent Developments
Table 81. Merck KGaA Basic Information List
Table 82. Merck KGaA Description and Business Overview
Table 83. Merck KGaA Recombinant DNA Technology Products, Services and Solutions
Table 84. Revenue (US$ Million) in Recombinant DNA Technology Business of Merck KGaA (2019-2024)
Table 85. Merck KGaA Recent Developments
Table 86. Profacgen Basic Information List
Table 87. Profacgen Description and Business Overview
Table 88. Profacgen Recombinant DNA Technology Products, Services and Solutions
Table 89. Revenue (US$ Million) in Recombinant DNA Technology Business of Profacgen (2019-2024)
Table 90. Profacgen Recent Developments
Table 91. Biocon Basic Information List
Table 92. Biocon Description and Business Overview
Table 93. Biocon Recombinant DNA Technology Products, Services and Solutions
Table 94. Revenue (US$ Million) in Recombinant DNA Technology Business of Biocon (2019-2024)
Table 95. Biocon Recent Developments
Table 96. GlaxoSmithKline Basic Information List
Table 97. GlaxoSmithKline Description and Business Overview
Table 98. GlaxoSmithKline Recombinant DNA Technology Products, Services and Solutions
Table 99. Revenue (US$ Million) in Recombinant DNA Technology Business of GlaxoSmithKline (2019-2024)
Table 100. GlaxoSmithKline Recent Developments
Table 101. Cibus Basic Information List
Table 102. Cibus Description and Business Overview
Table 103. Cibus Recombinant DNA Technology Products, Services and Solutions
Table 104. Revenue (US$ Million) in Recombinant DNA Technology Business of Cibus (2019-2024)
Table 105. Cibus Recent Developments
Table 106. Horizon Discovery Group Basic Information List
Table 107. Horizon Discovery Group Description and Business Overview
Table 108. Horizon Discovery Group Recombinant DNA Technology Products, Services and Solutions
Table 109. Revenue (US$ Million) in Recombinant DNA Technology Business of Horizon Discovery Group (2019-2024)
Table 110. Horizon Discovery Group Recent Developments
Table 111. New England Biolabs Basic Information List
Table 112. New England Biolabs Description and Business Overview
Table 113. New England Biolabs Recombinant DNA Technology Products, Services and Solutions
Table 114. Revenue (US$ Million) in Recombinant DNA Technology Business of New England Biolabs (2019-2024)
Table 115. New England Biolabs Recent Developments
Table 116. Key Raw Materials Lists
Table 117. Raw Materials Key Suppliers Lists
Table 118. Recombinant DNA Technology Downstream Customers
Table 119. Recombinant DNA Technology Distributors List
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
Table 123. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Recombinant DNA Technology Product Picture
Figure 2. Global Recombinant DNA Technology Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Recombinant DNA Technology Sales Value (2019-2030) & (US$ Million)
Figure 4. Recombinant DNA Technology Report Years Considered
Figure 5. Global Recombinant DNA Technology Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Recombinant DNA Technology Revenue in 2023
Figure 7. Recombinant DNA Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Therapeutic Agent Picture
Figure 9. Vaccine Picture
Figure 10. Biotech Crops Picture
Figure 11. Specialty Chemicals Picture
Figure 12. Global Recombinant DNA Technology Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Recombinant DNA Technology Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Biotechnology and Pharmaceutical Companies
Figure 15. Product Picture of Academic & Government Research Institutes
Figure 16. Product Picture of Others
Figure 17. Global Recombinant DNA Technology Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Recombinant DNA Technology Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Recombinant DNA Technology Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Recombinant DNA Technology Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Recombinant DNA Technology Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Recombinant DNA Technology Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Recombinant DNA Technology Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Recombinant DNA Technology Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Recombinant DNA Technology Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Recombinant DNA Technology Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Recombinant DNA Technology Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Recombinant DNA Technology Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Recombinant DNA Technology Sales Value (%), (2019-2030)
Figure 30. United States Recombinant DNA Technology Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Recombinant DNA Technology Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Recombinant DNA Technology Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Recombinant DNA Technology Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Recombinant DNA Technology Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Recombinant DNA Technology Sales Value by Application (%), 2023 VS 2030
Figure 36. China Recombinant DNA Technology Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Recombinant DNA Technology Sales Value by Type (%), 2023 VS 2030
Figure 38. China Recombinant DNA Technology Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Recombinant DNA Technology Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Recombinant DNA Technology Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Recombinant DNA Technology Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Recombinant DNA Technology Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Recombinant DNA Technology Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Recombinant DNA Technology Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Recombinant DNA Technology Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Recombinant DNA Technology Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Recombinant DNA Technology Sales Value by Application (%), 2023 VS 2030
Figure 48. India Recombinant DNA Technology Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Recombinant DNA Technology Sales Value by Type (%), 2023 VS 2030
Figure 50. India Recombinant DNA Technology Sales Value by Application (%), 2023 VS 2030
Figure 51. Recombinant DNA Technology Industrial Chain
Figure 52. Recombinant DNA Technology Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232